Why the study?
Coronary artery bypass grafting (CABG) has evolved alongside advances in percutaneous coronary intervention (PCI), with recent trials showing favorable outcomes for CABG in patients with diabetes or multivessel disease.
This review emphasizes the ongoing superiority of CABG in complex patients (diabetes, multivessel disease) and the critical role of the Heart Team approach in selecting revascularization strategies.
冠動脈バイパス術(CABG) は，経皮的冠動脈形成術の進歩とともに，お互いの成績を比較されながら発展してきた．最近の無作為試験の結果では，糖尿病や多枝病変の患者で冠動脈バイパス術の成績が良好であるとの報告が多い．冠動脈バイパス術は，オフポンプ ABG, minimally invasive direct coronary artery bypass, ハイブリッドCABG，ロボット支援CABG などの低侵襲化手術の流れである．虚血性心疾患は，患者背景や冠動脈病変を考慮して，心臓外科医と循環器内科医が密な連携のもとに治療方法を選択する必要がある．
No takes yet. Share an insight, caveat, or question.
Unosawa et al. (2017) conducted a review in Ischemic heart disease. Coronary artery bypass grafting (CABG) vs. Percutaneous coronary intervention (PCI) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: